MAGEA3 and melanoma: Further analysis showed that the risk score was predictable for the patients’ response to immunotherapy in dataset GSE35640 (Figure 7H, AUC=0.753), indicating risk score had a good predictablity in evaluating the sensitivity of melanoma patient towards immunotherapy like MAGE-A3 cancer immunotherapeutic.